Skip to main content
SpringerLink
Log in

Komplikationsmanagement nach Residualtumorresektion bei metastasiertem Hodentumor

Management of complications after residual tumor resection for metastatic testicular cancer

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Bei Patienten mit metastasiertem Hodentumor ist die Residualtumorresektion (RTR) nach Chemotherapie Therapie der Wahl. Sie kann entweder unilateral oder als ausgedehnte bilaterale RTR durchgeführt werden. Häufig werden zusätzliche Prozeduren notwendig, beispielsweise Nephrektomie, Splenektomie, Wirbelkörperersatz, Organteilresektionen wie Leberteilresektion oder partielle Darmresektion sowie Gefäßersatz. Entsprechend vielfältig können die intra- und postoperativen Komplikationen sein. In unserer Publikation gehen wir auf mögliche Früh- und Spätkomplikationen der RTR bei metastasierten Hodentumoren mit Behandlungs- und Vermeidungsstrategien ein.

Abstract

Residual tumor resection (RTR) in patients with metastatic testicular cancer plays a pivotal role in a multimodal treatment. It can be performed unilaterally or as an extended bilateral RTR. Additional surgical procedures might be necessary, such as nephrectomy, splenectomy, partial colectomy, or vascular interventions with possible caval resection, cavotomy, or aortic resection with aortic grafting. Consequently, several complications can be seen in the intra- and postoperative course, most common of which are superficial wound infections, intestinal paralysis, lymphocele, and chylous ascites. We sought to describe complication management and how to prevent complications before they arise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7

Literatur

  1. American Cancer Society (2014) Cancer facts & figures 2014. American Cancer Society, Atlanta

  2. Stephenson AJ, Tal R, Sheinfeld J (2006) Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. J Urol 176(5):1996–1999

    Article  PubMed  Google Scholar 

  3. Hendry WF, Norman AR, Dearnaley DP et al (2002) Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 94(6):1668–1676

    Article  PubMed  Google Scholar 

  4. Winter C, Pfister D, Busch J et al (2012) Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group. Eur Urol 61(2):403–409

    Article  PubMed  Google Scholar 

  5. Albers P, Bingoel C, Witthuhn R et al (2009) Complications of postchemotherapy residual tumor resection in patients with germ cell cancer. J Clin Oncol 27 (Suppl):e16077

    Google Scholar 

  6. Baniel J, Foster RS, Rowland RG et al (1995) Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 153(3 Pt 2):976–980

    Article  CAS  PubMed  Google Scholar 

  7. Luz MA, Kotb AF, Aldousari S et al (2010) Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor. World J Surg Oncol 8:97. DOI 10.1186/1477-7819-8-97

    Article  PubMed Central  PubMed  Google Scholar 

  8. Heidenreich A, Ohlmann C, Hegele A (2005) Repeat retroperitoneal lymphadenectomy in advanced testicular cancer. Eur Urol 47(1):64–71

    Article  PubMed  Google Scholar 

  9. Donohue JP, Thornhill JA, Foster RS et al (1993) Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965–1989): modifications of technique and impact on ejaculation. J Urol 149:237–243

    CAS  PubMed  Google Scholar 

  10. Heidenreich A, Albers P, Hartmann M et al (2003) Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 169(5):1710–1714

    Article  PubMed  Google Scholar 

  11. Leibovitch I, Mor Y, Golomb J et al (2002) The diagnosis and management of postoperative chylous ascites. J Urol 167:449–457

    Article  PubMed  Google Scholar 

  12. Mosharafa AA, Foster RS, Koch MO et al (2004) Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 171:1839–1841

    Article  PubMed  Google Scholar 

  13. Goldiner PL, Schweizer O (1979) The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol 6(1):121–124

    CAS  PubMed  Google Scholar 

  14. Djaladat H, Nichols C, Daneshmand S (2012) Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol 19(7):2388–2393

    Article  PubMed  Google Scholar 

  15. Cary KC, Beck S, Bihrle R et al (2013) Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection. J Urol 189(3):812–817

    Article  PubMed  Google Scholar 

  16. Winter C, Pfister D, Bingoel C et al (2011) Predictive factors for additional vascular procedures in patients with germ cell tumors (GCT) and residual tumor resection (RTR): A multicenter analysis of the german testicular cancer study groups (GTCSG). J Clin Oncol 29(Suppl):e15050

    Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. A. Lusch, M. Zaum, C. Winter und P. Albers geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Urologische Klinik, Heinrich-Heine Universität Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland

    A. Lusch, M. Zaum & P. Albers

  2. Klinik für Urologie, Malteser-Krankenhaus St. Josefshospital Uerdingen, Krefeld, Deutschland

    C. Winter

Authors
  1. A. Lusch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Zaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Albers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Lusch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lusch, A., Zaum, M., Winter, C. et al. Komplikationsmanagement nach Residualtumorresektion bei metastasiertem Hodentumor. Urologe 53, 991–995 (2014). https://doi.org/10.1007/s00120-014-3502-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-014-3502-8

Schlüsselwörter

Keywords

Search

Navigation